Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan

BSE689.6541.35 (+6.38 %)

PREV CLOSE ( ) 648.30

OPEN PRICE ( ) 655.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2535

TODAY'S LOW / HIGH ( )646.95 689.90

52 WK LOW / HIGH ( )548.05 829

NSE687.4538 (+5.85 %)

PREV CLOSE( ) 649.45

OPEN PRICE ( ) 654.50

BID PRICE (QTY) 687.45 (19)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 46159

TODAY'S LOW / HIGH( ) 642.10 692.35

52 WK LOW / HIGH ( )544.1 842.9

Select year

(Rs.in Million)

Particulars

Mar 2016

Mar 2015

Mar 2014

Mar 2013

Mar 2012

Profit Before Tax

326.83

241.49

193.80

154.74

161.20

Adjustment

-13.06

3.28

35.11

30.54

27.32

Changes In working Capital

8.11

32.16

19.13

-43.80

-101.32

Cash Flow after changes in Working Capital

321.89

276.93

248.05

141.49

87.21

Cash Flow from Operating Activities

206.99

183.15

174.48

86.20

36.22

Cash Flow from Investing Activities

41.61

-48.95

164.91

77.31

144.99

Cash Flow from Financing Activities

-131.04

-119.27

-139.16

-142.63

-273.09

Net Cash Inflow / Outflow

117.56

14.93

200.23

20.87

-91.88

Opening Cash & Cash Equivalents

306.67

291.73

91.50

70.62

244.27

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

424.23

306.67

291.73

91.50

152.39